Bank of Baroda reported net profit at Rs 4,541 crore for Q1 FY26. This marks a 2 percent rise from the Rs 4,458 crore net ...

Cipla Ltd (BOM:500087) reports robust financial performance with significant milestones in India and strategic advancements in the US market.

Cipla, Chennai Petroleum Corporation, Prataap Snacks, Jammu & Kashmir Bank, Reliance Infrastructure, SBI Cards and Tata ...

Balkrishna Industries, Lodha Developers, Whirlpool, ZEN Technologies, and SBFC Finance are also to release their April-June ...

Cipla is looking at the whole GLP-1 category and not just Semaglutide alone, says Cipla CEO Umang Vohra in a post-results ...

Total Income from operations rose to Rs 6,957 crore for the June quarter as compared with Rs 6,694 crore in the year-ago ...

Cipla consolidated net profit for the quarter ending June 2025 at ₹1291.61 crore was up 10% compared to ₹1175.46 crore in the ...

Porvorim: Blaming govt for doing little to ensure employment opportunities for locals, legislators on Friday said that ...

Indian pharmaceutical company, Cipla, aims to reach $1 billion in US sales by FY27, driven by upcoming product launches.

Cipla reported a 10% rise in Q1 PAT to ?1,298 crore, driven by India, Europe, and Africa sales. Revenue grew to ?6,957 crore despite a North America dip.

Cipla Health Ltd bagged the ‘Health & Wellness Company Of The Year’ award at the e4m Health & Wellness Marketing Awards 2025.